The DOI matches its Crossref record; 15 of the 15 references it cites were found in a registry or an index.
A High-Density Whole-Genome Association Study Reveals That APOE Is the Major Susceptibility Gene for Sporadic Late-Onset Alzheimer's Disease
Abstract
OBJECTIVE: While the apolipoprotein E (APOE) epsilon allele is a well-established risk factor for late-onset Alzheimer's disease (AD), initial genome scans using microsatellite markers in late-onset AD failed to identify this locus on chromosome 19. Recently developed methods for the simultaneous assessment of hundreds of thousands of single nucleotide polymorphisms (SNPs) promise to help more precisely identify loci that contribute to the risk of AD and other common multigenic conditions. We sought here to demonstrate that more precise identification of loci that are associated with complex, multi-genic genetic disorders can be achieved using ultra-high-density whole-genome associations by demonstrating their ability to identify the APOE locus as a major susceptibility gene for late-onset AD, despite the absence of SNPs within the APOE locus itself, as well as to refine odds ratios (ORs) based on gold-standard phenotyping of the study population. METHOD: An individualized genome-wide association study using 502,627 SNPs was performed in 1086 his-topathologically verified AD cases and controls to determine the OR associated with genes predisposing to Alzheimer's disease. RESULTS: As predicted, ultra-high-density SNP genotyping, in contrast to traditional microsatellite-based genome screening approaches, precisely identified the APOE locus as having a significant association with late-onset AD. SNP rs4420638 on chromosome 19, located 14 kilobase pairs distal to the APOE epsilon variant, significantly distinguished between AD cases and controls (Bonferroni corrected p value = 5.30 x 10(-34), OR = 4.01) and was far more strongly associated with the risk of AD than any other SNP of the 502,627 tested. CONCLUSION: This study provides empirical support for the suggestion that the APOE locus is the major susceptibility gene for late-onset AD in the human genome, with an OR significantly greater than any other locus in the human genome. It also supports the feasibility of the ultra-high-density whole-genome association approach to the study of AD and other heritable phenotypes. These whole-genome association studies show great promise to identify additional genes that contribute to the risk of AD.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Also, previous studies of clinically and neuropathologically characterized cases and controls may have been too small to demonstrate that APOE2 homozygotes have an even lower OR than the relatively low-risk APOE2/3 group due to the paucity of APOE2 homozygotes, who comprise <1% of the general population1,4.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“while the presence of one or two copies of the APOE2 allele is associated with a lower risk of Alzheimer’s dementia and an older mean age at dementia onset1–4.”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“Compared to the most common APOE3/3 genotype, each additional copy of the APOE4 allele is associated with a higher risk of Alzheimer’s dementia and a younger mean age at dementia onset, such that APOE4 homozygotes are at the highest risk”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“such that APOE4 homozygotes are at the highest risk”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“Apolipoprotein E (APOE), the major susceptibility gene for late-onset Alzheimer’s disease (AD), has three common alleles (APOE2, 3, and 4), giving rise to six genotypes (APOE2/2, 2/3, 3/3, 2/4, 3/4, and 4/4).”
From Exceptionally low likelihood of Alzheimer’s dementia in APOE2 homozygotes from a 5,000-person neuropathological study (2020) · cites this paper as [1]
In the citing paper
“All have identified strong evidence for association to APOE, but less convincing evidence implicating other genes2 -9 .”
From Genome-wide association study identifies variants at CLU and PICALM associated with Alzheimer's disease (2009) · cites this paper as [6]
In the citing paper
“The apolipoprotein E4 (APOE4) allele is the most common and important genetic risk factor for late-onset sporadic AD [19–21].”
From 25-Hydroxycholesterol amplifies microglial IL-1β production in an apoE isoform-dependent manner (2020) · cites this paper as [19]
In the citing paper
“Apolipoprotein (ApoE) is the major susceptibility gene for the common late-onset form of Alzheimer's disease and the presence of the ε4 allele increases the risk of developing AD [2].”
From Lack of LDL receptor enhances amyloid deposition and decreases glial response in an Alzheimer's disease mouse model (2011) · cites this paper as [2]
In the citing paper
“The first association studies covering most of the genome were published in 2007 [81, 82].”
From Genetic architecture of Alzheimer's disease (2020) · cites this paper as [81]
Citations
Cites
Haploview: analysis and visualization of LD and haplotype maps
Barrett, J. C., Fry, B., Maller, J., & Daly, M. J. (2004) · Bioinformatics · doi:10.1093/bioinformatics/bth457 · Cited by 14,563
Corder, E. H., Saunders, A. M., Strittmatter, W. J., Schmechel, D. E., Gaskell, P. C., Small, G. W., Roses, A. D., Haines, J. L., & Pericak-Vance, M. A. (1993) · Science · doi:10.1126/science.8346443 · Cited by 9,429
Association of apolipoprotein E allele ϵ4 with late‐onset familial and sporadic Alzheimer's disease
Saunders, A. M., Strittmatter, W. J., Schmechel, D., St. George-Hyslop, P. H., Pericak-Vance, M. A., Joo, S. H., Rosi, B. L., Gusella, J. F., Crapper-MacLachlan, D. R., Alberts, M. J., et al. (1993) · Neurology · doi:10.1212/wnl.43.8.1467 · Cited by 3,786
Systematic meta-analyses of Alzheimer disease genetic association studies: the AlzGene database
Bertram, L., McQueen, M. B., Mullin, K., Blacker, D., & Tanzi, R. E. (2007) · Nature Genetics · doi:10.1038/ng1934 · Cited by 1,857
Prospects for whole-genome linkage disequilibrium mapping of common disease genes
Kruglyak, L. (1999) · Nature Genetics · doi:10.1038/9642 · Cited by 1,416
Staging of Alzheimer-Related Cortical Destruction
Braak, H., Braak, E., & Bohl, J. (2008) · European Neurology · doi:10.1159/000116984 · Cited by 836
Single-Nucleotide Polymorphism Analysis by Pyrosequencing
Ahmadian, A., Gharizadeh, B., Gustafsson, A. C., Sterky, F. H., Nyrén, P., Uhlén, M., & Lundeberg, J. (2000) · Analytical Biochemistry · doi:10.1006/abio.2000.4493 · Cited by 433
A full genome scan for late onset Alzheimer's disease
Kehoe, P. G. (1999) · Human Molecular Genetics · doi:10.1093/hmg/8.2.237 · Cited by 357
Deciphering the Genetic Basis of Alzheimer's Disease
Selkoe, D. J., & Podlisny, M. B. (2002) · Annual Review of Genomics and Human Genetics · doi:10.1146/annurev.genom.3.022502.103022 · Cited by 303
Studies of familial type III hyperlipoproteinemia using as a genetic marker the apoE phenotype E2/2
Breslow, J. L., Zannis, V. I., SanGiacomo, T. R., Third, J. L., Tracy, T., & Glueck, C. J. (1982) · Journal of Lipid Research · doi:10.1016/s0022-2275(20)38060-3 · Cited by 174
Cited by
Sorted by citations
Items 401–500 of 572
LD‐informed deep learning for Alzheimer's gene loci detection using WGS data
Jo, T., Bice, P. J., Nho, K. T., Saykin, A. J., & Alzheimer's Disease Sequencing Project (2025) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.70041 · Cited by 5
Yoon, S., & Kim, Y. (2015) · Global Medical Genetics · doi:10.3934/genet.2015.3.230 · Cited by 5
Goldstein, L. S. B., & Das, U. (2020) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2020.08.001 · Cited by 5
Liu, X., Zeng, Q., Luo, X., Li, K., Hong, H., Wang, S., Guan, X., Wu, J., Zhang, R., Zhang, T., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.591347 · Cited by 5
Schramm, S. H., Jokisch, M., Jöckel, K., Herring, A., & Keyvani, K. (2021) · Alzheimer s Research & Therapy · doi:10.1186/s13195-021-00945-x · Cited by 5
Vulnerability to Substance Abuse
Uhl, G. R., Drgon, T., Johnson, C., & Liu, Q. (2010) · Springer eBooks · doi:10.1007/978-1-4419-0338-9_10 · Cited by 5
Baseline CSF/Serum-Ratio of Apolipoprotein E and Rate of Differential Decline in Alzheimer’s Disease
Schmidt, C., Gerlach, N., Schmitz, M., Thom, T., Kramer, K., Friede, T., & Zerr, I. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-150286 · Cited by 5
Aging, cognitive decline, apolipoprotein E and docosahexaenoic acid metabolism
Plourde, M. (2018) · OCL · doi:10.1051/ocl/2018032 · Cited by 5
A novel similarity-measure for the analysis of genetic data in complex phenotypes
Lagani, V., Montesanto, A., Cianni, F. D., Moreno, V. R., Landi, S., Conforti, D., Rose, G., & Passarino, G. (2009) · BMC Bioinformatics · doi:10.1186/1471-2105-10-s6-s24 · Cited by 5
Blom, E. S., Giedraitis, V., Arepalli, S., Hamshere, M. L., Adighibe, O., Goate, A., Williams, J. H., Lannfelt, L., Hardy, J., Vrièze, F. W., et al. (2009) · BMC Medical Genetics · doi:10.1186/1471-2350-10-122 · Cited by 5
Self-citationGenetics of Alzheimer´S Disease
Campos‐Peña, V., Gmez, R., & Antônio, M. (2014) · InTech eBooks · doi:10.5772/58286 · Cited by 5
Long-term effects of the cholesterol level and its drug treatment
Hyttinen, L. (2011) · Cited by 5
Genetics of A lzheimer's Disease
Brookes, K. J., & Morgan, K. (2017) · Wiley eBooks · doi:10.1002/9780470015902.a0020228.pub2 · Cited by 6
D’Angiolini, S., Gugliandolo, A., Calì, G., & Chiricosta, L. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26157303 · Cited by 4
Association of Insulin Receptor Substrate-1 Gene Polymorphism (rs1801278) with Alzheimer’s Disease
Niyasti, P., Saberi, A., Hatamyain, H., Ajamian, F., Shirkouhi, S. G., Mirzanejad, L., & Andalib, S. (2022) · Journal of Alzheimer s Disease Reports · doi:10.3233/adr-210060 · Cited by 4
Genetics of Alzheimer’s Disease: Lessons Learned in Two Decades
Taner, N. (2010) · DOAJ (DOAJ: Directory of Open Access Journals) · Cited by 4
ICAM1 gene polymorphism in late-onset Alzheimer’s disease
Shawkatová, I., Javor, J., Párnická, Z., Minárik, G., Vašečková, B., Králová, M., Pečeňák, J., Režnáková, V., Filipčík, P., & Ďurmanová, V. (2019) · Biologia · doi:10.2478/s11756-019-00295-y · Cited by 4
Sillén, A., Brohede, J., Forsell, C., Lilius, L., Andrade, J., Odeberg, J., Kimura, T., Winblad, B. G., & Graff, C. (2011) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000323808 · Cited by 4
Genetic and Blood Biomarkers of Alzheimer`s Disease
Momeni, P., & Ferrari, R. (2010) · The Open Nuclear Medicine Journal · doi:10.2174/1876388x01002010012 · Cited by 4
Zhang, H., Kok, V. C., Chuang, S., Tseng, C., Lin, C., Li, T., Sung, F.-C., Wen, C. P., Hsiung, C. A., & Hsu, C. Y. (2020) · Current Alzheimer Research · doi:10.2174/1567205017666200103112443 · Cited by 4
MOLECULAR GENETIC STUDIES OF MELANOCORTIN RECEPTORS IN MORBID OBESITY
Valli‐Jaakola, K. (2007) · Työväentutkimus Vuosikirja · Cited by 4
Deciphering the tissue-specific functional effect of Alzheimer risk SNPs with deep genome annotation
Varathan, P., He, B., He, B., Saykin, A. J., Nho, K. T., & Yan, J. (2024) · BioData Mining · doi:10.1186/s13040-024-00400-1 · Cited by 3
Shi, Y., Hu, J., Liu, W. J., Qiu, W. Q., He, X., Zhang, M., Gao, Y., Zhang, X., & Fan, Z. (2024) · Ophthalmology Glaucoma · doi:10.1016/j.ogla.2024.07.009 · Cited by 3
Dementia: Genes, Environments, Interactions
Gatz, M., Jang, J. Y., Karlsson, I., & Pedersen, N. L. (2013) · Springer eBooks · doi:10.1007/978-1-4614-7447-0_7 · Cited by 3
A simple and efficient algorithm for genome‐wide homozygosity analysis in disease
Liu, W., Ding, J., Gibbs, J. R., Wang, S., Hardy, J., & Singleton, A. (2009) · Molecular Systems Biology · doi:10.1038/msb.2009.53 · Cited by 3
Self-citationCOVID-19 Mortality and the Cytokine Storm: An Added Value for APOE Genotyping
Diambra, L. A., & Rastmanesh, R. (2022) · Coronaviruses · doi:10.2174/2666796704666221205152504 · Cited by 3
Cai, Y., Fu, P., & Zhang, X. (2023) · Neuroscience Letters · doi:10.1016/j.neulet.2023.137161 · Cited by 3
Zinkunegi, A. J., Bruno, D., Betthauser, T. J., Langhough, R. E., Asthana, S., Chin, N. A., Hermann, B. P., Johnson, S. C., & Mueller, K. D. (2023) · The Clinical Neuropsychologist · doi:10.1080/13854046.2023.2223389 · Cited by 3
Khalili-Moghadam, F., Nejad, J. H., Badri, T., Sadeghi, M., & Gharechahi, J. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e37556 · Cited by 3
Genetics of Vascular Dementia.
Murray, M. E., Meschia, J. F., Dickson, D. W., & Ross, O. A. (2010) · PubMed · Cited by 3
Robert, J., Cheng, W. H., Hayat, A., Ward-Able, T., & Wellington, C. L. (2015) · Clinical Lipidology · doi:10.2217/clp.14.64 · Cited by 3
Genetics and hepatitis C: It’s good to be ‘CC’
Parungao, J. M., Hanouneh, I. A., John, B. V., Alkhouri, N., & Zein, N. N. (2015) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.82a.14004 · Cited by 3
Salminen, L. E., Schofield, P. R., Pierce, K. D., Luo, X., Zhao, Y., Laidlaw, D. H., Cabeen, R. P., Conturo, T. E., Lane, E., Heaps, J. M., et al. (2015) · Journal of Neural Transmission · doi:10.1007/s00702-015-1434-0 · Cited by 3
Naha, N., Das, M., & Banerjee, A. (2018) · Journal of Alcoholism and Drug Dependence · doi:10.4172/2329-6488.1000309 · Cited by 3
Genetics of Restless Legs Syndrome
Xiong, L., Turecki, G., Levchenko, А., Gaspar, C., Hening, W. A., Montplaisir, J. Y., & Rouleau, G. A. (2009) · Elsevier eBooks · doi:10.1016/b978-075067518-5.10008-4 · Cited by 3
Identification of Alzheimer Risk Factors Through Whole-Genome Analysis
Hardy, J., & Williams, J. H. (2010) · Archives of Neurology · doi:10.1001/archneurol.2010.97 · Cited by 3
Self-citationYu, D., Wang, L., Kong, D., & Hongtu Zhu, B. (2020) · arXiv (Cornell University) · Cited by 3
Locus- and Gene-Level Insights into the Inverse Association Between Alzheimer’s Disease and Cancer
Debnath, D., Housini, M., Sariya, S., Phillips, N. R., Pathak, G. A., & Barber, R. C. (2026) · International Journal of Molecular Sciences · doi:10.3390/ijms27062900 · Cited by 2
Schuler, A. (2021) · The International Journal of Biostatistics · doi:10.1515/ijb-2021-0039 · Cited by 2
The Association between Retinal Vascular Occlusions and Dementia
Gao, A., Tuz‐Zahra, F., Vig, V., Zeng, R., Tripodis, Y., Stein, T. D., Alosco, M. L., Ness, S. D., Chen, X., Siegel, N. H., et al. (2025) · Ophthalmology Retina · doi:10.1016/j.oret.2025.08.010 · Cited by 2
Gene Mapping and Human Disease
Terwilliger, J. D. (2022) · Springer eBooks · doi:10.1007/978-3-030-95350-8_6 · Cited by 2
Impact of Environmental Pollutants on Alzheimer’s Disease: A Review
Srivastava, Y., Chauhan, A. P. S., & Singh, S. B. (2022) · Nature Environment and Pollution Technology · doi:10.46488/nept.2022.v21i04.022 · Cited by 2
Gottschalk, W. K., Mahon, S., Hodgson, D., Barrera, J., Hill, D., Wei, A. L., Kumar, M., Dai, K. Z., Anderson, L., Mihovilovic, M., et al. (2023) · Journal of Alzheimer s Disease · doi:10.3233/jad-230451 · Cited by 2
Dissecting the Immune System through Gene Regulation
Yoshida, H. (2024) · Advances in experimental medicine and biology · doi:10.1007/978-981-99-9781-7_15 · Cited by 2
IRS gene polymorphisms in Turkish patients with late-onset Alzheimer’s disease
Özkan, H., Yildiz, M., Üstündağ, A., Kara, İ. H., Güldiken, B., Süt, N., & Sipahi, T. (2025) · Molecular Biology Reports · doi:10.1007/s11033-025-10352-2 · Cited by 2
Shelton, M. G., Kerns, K. A., Shirali, S., Castora, F. J., & Coleman, R. A. (2025) · Journal of Alzheimer s Disease · doi:10.1177/13872877251362889 · Cited by 2
Association of Alzheimer's Disease with Promoter Variations in NPY2R Gene
Karimzadeh, M. R., Najmadini, A., Azhdari, S., Zatalian, N., Zandi, F., Salmani, N., & Saeidi, K. (2025) · Reports of Biochemistry and Molecular Biology · doi:10.61882/rbmb.13.4.507 · Cited by 2
Using Genomic Data to Make Indirect (and Unauthorized) Estimates of Disease Risk
Nyholt, D. R. (2012) · Public Health Genomics · doi:10.1159/000336546 · Cited by 2
Schaeffer, M. J., Initiative, A. D. N., & Callahan, B. L. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-180962 · Cited by 2
Rosenberg, R. N. (2009) · JAMA · doi:10.1001/jama.2009.80 · Cited by 2
CASE REPORT OF A PATIENT WITH RARE P.ARG136CYS (APOE2*) MUTATION IN APOLIPOPROTEIN E GENE
Lisyova (2014) · OnLine Journal of Biological Sciences · doi:10.3844/ojbsci.2014.36.43 · Cited by 2
Genetics and Genomics of Dementia
Nussbaum, R. L. (2010) · Elsevier eBooks · doi:10.1016/b978-0-12-374934-5.00053-2 · Cited by 2
Genetics of Brain and Cognition and Their Interactions with Dietary and Environmental Factors
Ordovás, J. M. (2015) · CRC Press eBooks · doi:10.1201/b18563-5 · Cited by 2
Metheetrairut, C., Ahuja, Y., & Slack, F. J. (2017) · Cell Cycle · doi:10.1080/15384101.2017.1344798 · Cited by 2
Candidate gene studies in human anxiety disorders
Donner, J. (2012) · Työväentutkimus Vuosikirja · Cited by 2
Rosenberg, R. N., Stüve, O., & Eagar, T. N. (2009) · Archives of Neurology · doi:10.1001/archneurol.2008.580 · Cited by 2
Next Generation of Genotype Imputation Methods
Das, S. (2017) · Deep Blue (University of Michigan) · Cited by 2
Possible genetic factors related to hormone treatment effects
Hogervorst, E., Henderson, V. W., Gibbs, R. B., & Brinton, R. D. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.016 · Cited by 2
Genetic and Genomic Aspects of Alzheimer's Disease
Chua, S.-M., Ng, B.-Y., & Lee, T.-S. W. (2010) · Proceedings of Singapore Healthcare · doi:10.1177/201010581001900408 · Cited by 1
Shorter Telomere Length in Individuals with Neurocognitive Disorder and APOE ε4 Genotype
Mejía-Ortiz, P., Mendoza, A. D. G., Villanueva, R. R., Ramírez, S. L., Sánchez, R. G., Fernández, T., Sigg-Alonso, J., & Nicolini, H. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26104577 · Cited by 1
Valdez-Gaxiola, C. A., Rosales-Leycegui, F., Gaxiola-Rubio, A., Dumois‐Petersen, S., Gallegos‐Arreola, M. P., Ringman, J. M., & Figuera, L. E. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26167929 · Cited by 1
F4‐01‐02: Alzheimer's disease genetics: Current status and future perspectives
Bertram, L. (2009) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2009.05.507 · Cited by 1
Genetics and genomics in human lung transplantation
Garantziotis, S., & Palmer, S. M. (2007) · Expert Review of Respiratory Medicine · doi:10.1586/17476348.1.2.271 · Cited by 1
P3‐196: A genome‐wide association study for late‐onset Alzheimer's disease using DNA pooling
Abraham, R., Georgieva, L., Sims, R., Morgan, A. R., Hollingworth, P., Lovestone, S., Brayne, C., Cichon, S., O’Donovan, M. C., Williams, J. H., et al. (2008) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2008.05.1762 · Cited by 1
Informative Bayesian Model Selection: a method for identifying interactions in genome-wide data
Aflakparast, M., Masoudi‐Nejad, A., Bozorgmehr, J. H., & Visweswaran, S. (2014) · Molecular BioSystems · doi:10.1039/c4mb00123k · Cited by 1
Genetic Contributions to Individual Differences in Vulnerability to Addiction and Abilities to Quit
Uhl, G. R., & Drgon, T. (2012) · Springer eBooks · doi:10.1007/978-1-4614-3375-0_7 · Cited by 1
Golden, E. C., & Josephs, K. A. (2014) · Cambridge University Press eBooks · doi:10.1017/cbo9781107588660.002 · Cited by 1
Brain Functional Imaging in Preclinical Alzheimer’s Disease
Häussermann, P., Bartsch, T., & Granert, O. (2018) · Neuromethods · doi:10.1007/978-1-4939-7674-4_8 · Cited by 1
Genotype–phenotype considerations in neurogenetic disease
Fogel, B. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813955-4.00004-0 · Cited by 1
Alzheimer-Like Cell Alterations after Vanadium Pentoxide Inhalation
Dorado-Martı́nez, C., Montiel-Flores, E., Mejía-García, O. A., Ordóñez-Librado, J. L., Gutiérrez-Valdez, A. L., Espinosa-Villanueva, J., Erazo, L. R., Tron-Alvarez, R., Rodríguez-Lara, V., & Ávila-Costa, M. R. (2021) · IntechOpen eBooks · doi:10.5772/intechopen.100468 · Cited by 1
Peter, J., & Klöppel, S. (2015) · Elsevier eBooks · doi:10.1016/b978-0-12-397025-1.00073-7 · Cited by 1
Cruchaga, C., Kauwe, J. S. K., & Goate, A. (2012) · Cambridge University Press eBooks · doi:10.1017/cbo9781139025997.032 · Cited by 1
Han, L., Jiang, H., Yao, X., Ren, Z., Qu, Z., Yu, T., Luo, S., & Wu, T. (2023) · Quantitative Imaging in Medicine and Surgery · doi:10.21037/qims-22-602 · Cited by 1
Şahin, K., & Rüstemoğlu, A. (2023) · Nucleosides Nucleotides & Nucleic Acids · doi:10.1080/15257770.2023.2253282 · Cited by 1
Shifting Paradigm in Early Detection and Prediction of Alzheimer's Disease
Bashir, T., Akhouri, D., & Hamza, H. (2024) · Advances in medical technologies and clinical practice book series · doi:10.4018/979-8-3693-1090-8.ch013 · Cited by 1
The General Concepts of Gene Mapping: Linkage, Association, Linkage Disequilibrium and Marker Maps
Laird, N. M., & Lange, C. (2010) · Statistics for biology and health · doi:10.1007/978-1-4419-7338-2_5 · Cited by 1
Frecuencias genotípicas y alélicas de apolipoproteina e (APOE) en una muestra de adultos en Bogotá
Gómez, C. R., Gutiérrez-Castañeda, L. D., Pedraza, O. L., Torres-Tobar, L. A., Acevedo, G. H., Suárez, A., Lozano-Ruiz, A. G., & Camacho, I. (2021) · Revista Repertorio de Medicina y Cirugía · doi:10.31260/repertmedcir.01217372.1008 · Cited by 1
Identification and Functional Characterization of Genetic Risk Factors in Alzheimer´s Disease
Eckart, K. (2009) · Electronic Theses of LMU Munich (Ludwig-Maximilians-Universität München) · doi:10.5282/edoc.10259 · Cited by 1
Genetic studies of the common epilepsies: genome-wide association studies in the partial epilepsies
Catarino, C. B. (2014) · UCL Discovery (University College London) · Cited by 1
Ancestralidade da população de São Paulo e correlação com alterações neuropatológicas no idoso
Schlesinger, D. (2010) · Digital Library of Theses and Dissertations (Universidade de São Paulo) · doi:10.11606/t.41.2010.tde-17122010-142628 · Cited by 1
Sjölander, A. (2007) · Gothenburg University Publications Electronic Archive (Gothenburg University) · Cited by 1
Alzheimer Disease, Genetics of
Kehoe, P. G. (2008) · Wiley eBooks · doi:10.1002/9780470015902.a0020228 · Cited by 1
What are we willing to accept for preventing Alzheimer's disease? – Investigators' reply
Tariot, P. N., Langbaum, J. B. S., & Reiman, E. M. (2016) · The Lancet Neurology · doi:10.1016/s1474-4422(16)30055-2 · Cited by 1
Self-citationA Haplotype-Based Permutation Approach in Gene-Based Testing
Brand, H. (2013) · D-Scholarship@Pitt (University of Pittsburgh)
Methodological Approaches to Study the Genetics of Dementia and Cognitive Function
Liu, F. (2009) · RePub (Erasmus University Rotterdam)
ROLE OF GENOMIC COPY NUMBER VARIATION IN ALZHEIMER'S DISEASE AND MILD COGNITIVE IMPAIRMENT
Swaminathan, S. (2013) · IUScholarWorks (Indiana University) · doi:10.7912/c2/1949
Chapuis, J., & Lambert, J. (2008) · OpenGrey (Institut de l'Information Scientifique et Technique)
Susceptibility genes in conformational diseases
von Otter, M. (2009) · Gothenburg University Publications Electronic Archive (Gothenburg University)
Alzheimer’s Disease Genomics and Clinical Applications
Lee, T.-S. W., & Sian, M. (2011) · InTech eBooks · doi:10.5772/18773
Genetic Determinants of Cognitive Function and Age-Related Brain Changes
Schuur, M. (2010) · RePub (Erasmus University Rotterdam)
Genomics and bioinformatics strategies in the study of aging and Alzheimer disease
Hong, M. (2011) · Figshare
Shu, H. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511581410.003
Common neurodegenerative diseases: Dissection by genome-wide association
Bonifati, V. (2007) · Current Neurology and Neuroscience Reports · doi:10.1007/s11910-007-0065-8
P2‐030: INVESTIGATING THE ROLE OF CLU, PICALM, AND CR1 IN ALZHEIMER'S DISEASE
Lord, J., Turton, J. C., Braae, A., Barber, I., Medway, C., Brown, K. S., & Morgan, K. (2014) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2014.05.703
Association studies on susceptibility genes in Alzheimer disease
Björk, B. F. (2008) · Figshare
Determinants and Outcomes of Structural Brain Changes
Ikram, M. A. (2009) · RePub (Erasmus University Rotterdam)
Mbbs, M. F., Verma, M., Kaur, H., Kumar, A., Srivastava, Kukreti, R., Mukhopadhyay, A., Ganguly, N. K., Taneja, V., & Faruq, M. (2014)
Genetics related to sex steroids: implications for Alzheimer's disease
Talbot, C. J. (2009) · Cambridge University Press eBooks · doi:10.1017/cbo9780511635700.017
Metadata
- Authors
- Coon, K. D., Myers, A. J., Craig, D. W., Webster, J. A., Pearson, J. V., Lince, D. H., Zismann, V. L., Beach, T. G., Leung, D., Bryden, L., Halperin, R. F., Marlowe, L., Kaleem, M., Walker, D. G., Ravid, R., Heward, C. B., Rogers, J., Papassotiropoulos, A., Reiman, E. M., Hardy, J., & Stephan, D. A.
- Affiliations
- Translational Genomics Research Institute (US)
- University of Miami (US)
- Banner Sun Health Research Institute (US)
- National Institutes of Health (US)
- ORCID
- Venue
- The Journal of Clinical Psychiatry
- Publisher
- Physicians Postgraduate Press, Inc
- Published
- 2007-04-15
- Volume
- 68
- Issue
- 04
- Pages
- 613-618
- ISSN
- 0160-6689 (ISSN-L)
- OpenAlex
- W2017581860
- Cited by
- 569
- References
- 15
- Citations by year
- 2026: 4 · 2025: 18 · 2024: 15 · 2023: 37 · 2022: 32 · 2021: 26 · 2020: 23 · 2019: 23 · 2018: 28 · 2017: 20 · 2016: 21 · 2015: 22 · 2014: 29 · 2013: 28 · 2012: 42
- FWCI
- 36.06
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Journal of Clinical Psychiatry (publishedVersion)
- PubMed (publishedVersion)
- UCL Discovery (University College London) (submittedVersion)
- Zurich Open Repository and Archive (University of Zurich) (submittedVersion)
- Funders
- National Institute on Aging (U01AG016976)
- Topics
- Life Sciences › Neuroscience › Cellular and Molecular Neuroscience › Alzheimer's disease research and treatments
- Health Sciences › Medicine › Psychiatry and Mental health › Dementia and Cognitive Impairment Research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › Genetic Associations and Epidemiology
- Keywords
- late-onset Alzheimer's disease, apolipoprotein E, genetic susceptibility, single nucleotide polymorphisms, whole-genome association studies, chromosome 19, odds ratio, genetic susceptibility loci
- MeSH terms
- Aged, Aged, 80 and over, Alzheimer Disease, Apolipoproteins E, Brain, Chromosome Mapping, Chromosomes, Human, Pair 19, Female, Humans, Male, Risk Factors, Odds Ratio, Case-Control Studies, Age of Onset, Genetic Predisposition to Disease, Polymorphism, Single Nucleotide
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
